Estimates of effects, ranking, and certainty of evidence for different treatment options vs placebo
Sunitinib (1 RCT; 171 participants)
Estimates of effects, ranking, and certainty of evidence for… probably leads to lower sunitinib (1 RCT; 171 participants) compared with placebo (moderate certainty).
2 findings from 1 review
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyHR 0.42 [0.26, 0.67]1 study · 171 participantsModerate
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyOR 1.72 [0.91, 3.27]1 study · 171 participantsLow